News

Jun 2019

Cyntegrity Launches MyRBQM® Portal

By |2020-09-23T10:51:07+02:00June 14, 2019|News, RBQM Product Updates|Comments Off on Cyntegrity Launches MyRBQM® Portal

MyRBQM Portal is world's first one-stop clinical trial optimization solution and opens the door to fully fledged risk-based quality management. Get your free user license today!

Mar 2019

Your Practical Guide to Understanding Clinical KRIs

By |2024-11-25T17:56:46+02:00March 12, 2019|Free Infographics, News|1 Comment

Our key risk indicator infographic will give you a foundational understanding of KRIs, provide valuable examples of KRIs, and guide you towards getting started with your risk-based monitoring (RBM) program.

Nov 2018

Dr Johann Proeve awarded 2018 MCC Champion

By |2018-12-06T08:52:03+02:00November 15, 2018|News|Comments Off on Dr Johann Proeve awarded 2018 MCC Champion

MCC Congratulates the 2018 Class of MCC Champions: "MCC bestows this special honor to those individuals who made significant contributions in 2018 in advancing the MCC mission to improve the efficiency, quality and effectiveness of clinical trials."

Nov 2018

SCOPE Europe Summit 2018 – Reflection

By |2018-11-01T14:05:20+02:00November 1, 2018|News|Comments Off on SCOPE Europe Summit 2018 – Reflection

Zooming in on three key areas; analytics-driven feasibility, patient-centric enrolment planning and Risk-based Monitoring, SCOPE Europe professionally facilitated high level discussions between pharma industry leaders and decision makers.

Jul 2018

Press Release: Cyntegrity enters the Medical Devices Market

By |2019-04-02T11:07:31+02:00July 10, 2018|News|Comments Off on Press Release: Cyntegrity enters the Medical Devices Market

Cyntegrity today announced the worldwide release of their Medical Device RACT, “MD-RACT”, the world’s first Risk Assessment and Categorization Tool for clinical investigations, that combines the best practices in Life Sciences with subject matter expertise in Medical Devices.

May 2018

Interview: “Oncology Trials are Different”

By |2018-10-02T05:41:24+02:00May 3, 2018|Blog, News|Comments Off on Interview: “Oncology Trials are Different”

Many risks in clinical trials seem therapy specific. To illustrate this, Dr Johann Proeve shares real life use cases he experienced during his years as Head of Global Data Management at Bayer HealthCare.

May 2018

“OncoRACT” – The First Therapy Specific RACT for Clinical Trials

By |2020-09-23T10:54:27+02:00May 1, 2018|Neat Features, News, RBQM Product Updates|Comments Off on “OncoRACT” – The First Therapy Specific RACT for Clinical Trials

Many risks in clinical trials are therapy specific. Because of that, the currently available tools addressing those risks are now becoming therapy specific as well. The first therapy focused risk library Oncology RACT (OncoRACT) recently got available.

Go to Top